Screening for topoisomerase I binding compounds by high-performance liquid chromatography-mass spectrometry

Analytical Biochemistry

Volumn 329, Issue 2, 2004, Pages 173-179

  Zhang, Hong ^a,b   Gu, Qing ^a,b   Liang, Xinle ^b   Pan, Yuanjiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG GONGSHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROSPRAY IONIZATION; MASS SPECTROMETRY;

ACTIVE COMPOUNDS; BINDING ACTIVITIES; BINDING COMPOUNDS; COMPOUND SCREENINGS; DNA TOPOISOMERASE I; ELECTROSPRAY IONIZATION MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRIES; TARGET PROTEINS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

10 HYDROXYCAMPTOTHECIN; CAMPTOTHECIN; DAUNORUBICIN; DNA TOPOISOMERASE; DOXORUBICIN; RUBITECAN;

ARTICLE; BINDING AFFINITY; CELL CULTURE; DRUG BINDING; DRUG SCREENING; ELECTROSPRAY MASS SPECTROMETRY; ENZYME BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN TARGETING; ULTRAFILTRATION;

EID: 2542418322     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.03.057     Document Type: Article

References (14)

1. Gallop M.A., Barrett R.W., Dower W.J., et al. Applications of combinatorial technologies to drug discovery 1. Background and peptide combinatorial libraries. J. Med. Chem. 37:1994;1233-1251
2. Terrett N.K., Gardner M., Gordon D.W., et al. Combinatorial synthesis - the design of compound libraries and their application to drug discovery. Tetrahedron. 51:1995;8135-8173
3. Gordon E.M., Gallop M.A., Campbell D., et al. Combinatorial organic synthesis: applications to drug discovery. Eur. J. Med. Chem. 30:1995;337s-348s
4. Li Y.Y., Li Z.Y., Wang H., et al. Topoisomerases and anticancer drugs. Pharmaceut. Adv. 20(3):1996;138-142
5. Randall W.N., Jennifer R.K., Allan L.B., et al. Mass spectrometric immunoassay. Anal. Chem. 67:1995;1153-1158
6. Srewart L., Champoux J.J. Osheroff N., Bjornsti M.A. DNA Topoisomerase Protocols Part II. 2001;1-11 Humana Press, Totowa, NJ
7. Nicholas R.C. DNA gyrase and the supercoiling of DNA. Science. 207:1980;953
8. Lock R.B., Ross W.E. DNA topoisomerases in cancer therapy. Anti-cancer Drug Design. 2:1987;151-154
9. 1210 cells a target for screening antitumor agents. Cancer. 10:1991;220-225
10. Hsing Y.H., Hertzberg R., Hecht S., et al. CPT induces protein linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:1985;14873
11. Feng J.C., Zhang Y.J., Tan Y.D. The development in research on Camptotheca acuminata and utilization of camptothecin. Forestry Sci. (Chinese). 36:2000;100-108
12. Jensen P.B., Sehested M. DNA topoisomerase II rescue by catalytic inhibitors. Biol. Pharmacol. 54:1997;755-759
13. Hengel A.J.V., Harkes M.P., Wichers H.J., et al. Characterization of callus formation and camptothecin production by cell lines of Camptotheca acuminata. Plant Cell, Tissue Organ Culture. 28:1992;11-18
14. Sakato K., Tanaka H., Mukai N., et al. Isolation and identification of camptothecin from cells of Camptothca acuminata suspension cultures. Agr. Biol. Chem. 38:1974;217-218